標(biāo)題: Titlebook: Geriatric Oncology; Martine Extermann Living reference work 20200th edition Geriatric Oncology.Cancer.Elderly.Biology of Aging and Cancer [打印本頁(yè)] 作者: Croching 時(shí)間: 2025-3-21 17:50
書目名稱Geriatric Oncology影響因子(影響力)
書目名稱Geriatric Oncology影響因子(影響力)學(xué)科排名
書目名稱Geriatric Oncology網(wǎng)絡(luò)公開度
書目名稱Geriatric Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Geriatric Oncology被引頻次
書目名稱Geriatric Oncology被引頻次學(xué)科排名
書目名稱Geriatric Oncology年度引用
書目名稱Geriatric Oncology年度引用學(xué)科排名
書目名稱Geriatric Oncology讀者反饋
書目名稱Geriatric Oncology讀者反饋學(xué)科排名
作者: AND 時(shí)間: 2025-3-21 23:41
Aging and Cancer Biology,growth. The available data on the effects of environmental carcinogens on life span and the aging at different levels of integration are critically analyzed. The exposure to various mutagenic agents, i.e., 5-bromodeoxyuridine, alkylating substances, carcinogenic polycyclic aromatic hydrocarbons, nit作者: 眉毛 時(shí)間: 2025-3-22 01:49 作者: 廢墟 時(shí)間: 2025-3-22 05:55 作者: connoisseur 時(shí)間: 2025-3-22 12:06
Bladder Cancer in Older Adults, the impact of adjuvant intravesical immunotherapy might be inferior. Patients with muscle-invasive BC (MIBC) may benefit from a multidisciplinary geriatric evaluation. Radical cystectomy (RC) remains the curative treatment to BC, and elderly patients should not be withheld a potentially lifesaving 作者: Ornithologist 時(shí)間: 2025-3-22 16:38
Cellular Senescence and Tumor Promotion,cer therapeutic strategies are aimed to induce cancer cells to senesce. However, an excessive accumulation of senescent cells and their secretory phenotype can drive different pathologies associated with age, including cancer. Thus, cellular senescence can begin as a potent tumor suppressive mechani作者: Ornithologist 時(shí)間: 2025-3-22 17:48 作者: Accrue 時(shí)間: 2025-3-23 01:05 作者: gene-therapy 時(shí)間: 2025-3-23 02:45
Comprehensive Geriatric Assessment (CGA) for Cancer Patients,may be considered initially keeping in mind that they do not replace CGA. If abnormal, screening should be followed by CGA and guided multidisciplinary interventions. This chapter will describe the CGA domains, the most commonly used assessment tools, as well as the benefits of performing such asses作者: Observe 時(shí)間: 2025-3-23 08:23
Diffuse Large B-Cell Lymphomas in Older Adults,ombined modality therapy for limited stage disease, and strategies for the relapsed/refractory older patient. We will also address the issues of prognosis, comorbidities, geriatric assessment, supportive care measures in older patients with DLBCL, and recommendations for assessment and allied care.作者: Anal-Canal 時(shí)間: 2025-3-23 12:22 作者: adumbrate 時(shí)間: 2025-3-23 14:45
Living reference work 20200th edition SpringerReference program, in which this book is published, offers an ideal format for overcoming these limitations since it combines thorough coverage with access to living editions constantly updated chapter by chapter via a dynamic peer-review process, ensuring that information remains current a作者: Insufficient 時(shí)間: 2025-3-23 19:41 作者: 沙漠 時(shí)間: 2025-3-24 01:38
Experimentelle Nierenkrankheiten,ize therapies for older adults with AML, it is important to assess individual fitness through the use of a geriatric assessment. Improving outcomes of older adults with AML will rely on both development of novel therapies and targeting therapy to their physiologic fitness and disease biology.作者: 最初 時(shí)間: 2025-3-24 02:22 作者: freight 時(shí)間: 2025-3-24 10:08 作者: 極肥胖 時(shí)間: 2025-3-24 12:58
https://doi.org/10.1007/978-3-663-02424-8Telomere length decreases with cellular replication over time. Finally, repeated exposure to environmental stress results in cellular senescence. Researchers are now exploring biomarkers of these processes and their potential application in geriatric oncology. While they may not be pure aging biomar作者: Semblance 時(shí)間: 2025-3-24 18:41 作者: inundate 時(shí)間: 2025-3-24 22:32 作者: Pulmonary-Veins 時(shí)間: 2025-3-25 01:04
Elternbildung und Erziehungsberatungboring 17p deletion or TP53 mutation. In addition to ibrutinib, idelalisib plus rituximab and venetoclax are preferred therapies for older adults with relapsed or refractory CLL. Readministration of chemoimmunotherapy is an option in older adults with late recurrence of CLL.作者: FAZE 時(shí)間: 2025-3-25 05:03 作者: CRAFT 時(shí)間: 2025-3-25 10:24 作者: FANG 時(shí)間: 2025-3-25 14:43
Lebenswelten als Bildungsweltenombined modality therapy for limited stage disease, and strategies for the relapsed/refractory older patient. We will also address the issues of prognosis, comorbidities, geriatric assessment, supportive care measures in older patients with DLBCL, and recommendations for assessment and allied care.作者: impaction 時(shí)間: 2025-3-25 17:35
https://doi.org/10.1007/978-3-322-95992-8ay have more significant “downstream” effects on treatment adherence and persistence. However, as more anticancer drugs become available and adopted into clinical practice (particularly oral agents), additional studies will need to address PDIs within the dynamic landscape of cancer therapeutics and作者: GRACE 時(shí)間: 2025-3-25 22:50 作者: 追逐 時(shí)間: 2025-3-26 02:29 作者: 曲解 時(shí)間: 2025-3-26 06:59 作者: 有常識(shí) 時(shí)間: 2025-3-26 08:48
https://doi.org/10.1007/978-3-663-02424-8, the ability to recover from major stresses on the body such as cancer treatment becomes more difficult. Varying degrees of frailty can be subtle, which explains the difficulty of distinguishing which older adults will have excess toxicity from cancer therapy and ones will tolerate it well. Thus, a作者: 不合 時(shí)間: 2025-3-26 13:10
Gerd B. Achenbach,Martina Winkler-Calaminusllenge to manage in a very close future. However, the current treatment of BC in the elderly remains controversial. The purpose of this article is to review the previous literature to summarize and gather the current knowledge in order to describe the management and treatment of BC in the elderly, i作者: 我的巨大 時(shí)間: 2025-3-26 18:57 作者: 上坡 時(shí)間: 2025-3-26 22:23
Erzieherinnen in Beruf und Freizeites. Thus, cellular senescence derives from stress-activated programs, as opposed to other cellular states of irreversible growth arrest, such as post-mitosis and terminal differentiation, which are a consequence of developmental-activated programs. Senescent cells are characterized by the expression作者: 相反放置 時(shí)間: 2025-3-27 04:33 作者: TIA742 時(shí)間: 2025-3-27 07:21 作者: 口訣法 時(shí)間: 2025-3-27 13:27 作者: 皺痕 時(shí)間: 2025-3-27 14:31
https://doi.org/10.1007/978-3-663-09990-1molecular genetic features, and outcome. Major recent advances in understanding the molecular pathogenesis of many primary CNS tumors have resulted in a revision of the World Health Organization (WHO) classification of brain tumors in 2016. Secondary CNS tumors are represented by brain and leptomeni作者: sundowning 時(shí)間: 2025-3-27 19:20
https://doi.org/10.1007/978-3-531-92887-6lder patients. From all angles, it is clear that older patients are unique and their colorectal cancer care should be individualized and approached in a multidisciplinary fashion. Evaluation of patient fitness to undergo surgery should be undertaken in the elective and emergent settings. If patients作者: Immobilize 時(shí)間: 2025-3-27 22:38
,Nationalsozialistische P?dagogik, with specific characteristics. Standards of care cannot therefore be transposed from young to elderly patients. Tumor resection is frequently performed, but adjuvant chemotherapy is rarely prescribed as there are no clearly established standards of care. In a metastatic setting, recent phase III st作者: cardiopulmonary 時(shí)間: 2025-3-28 03:13
https://doi.org/10.1007/978-3-531-90924-0 manifold presentation; numerous measures have been developed and validated, but there is no “gold standard” for comorbidity measurement in patients with cancer. However, a few tools have been developed specifically for quantification of comorbidity in older adults and/or patients with cancer. Comor作者: 我悲傷 時(shí)間: 2025-3-28 09:35 作者: Commonwealth 時(shí)間: 2025-3-28 12:11
Erziehung, Bildung und Geschlechtent is the decision making that occurs prior to treatment and safety considerations that need to be highlighted. As more older individuals with cognitive impairment, multicomorbidity, and polypharmacy are treated, a balance between improved morbidity and mortality must be made against safety issues 作者: 熄滅 時(shí)間: 2025-3-28 14:52
Lebenswelten als Bildungsweltenficant therapeutic advances have recently been made in the care of older DLBCL patients, based upon results of randomized clinical trials, many older patients are not eligible for such trials due to comorbidities and functional decline. Pretreatment evaluation of older patients to ascertain potentia作者: 形上升才刺激 時(shí)間: 2025-3-28 21:46
Daniel M?hle,Heinz-Roland M?hle incidence above 75 years, and diagnosis in the elderly is done at more advanced stages..Management is complex with intensive treatments combining all available anticancer modalities of treatment depending on stage: major surgery, radiotherapy, chemotherapy, radio-chemotherapy, targeted therapy, etc作者: optional 時(shí)間: 2025-3-29 00:44
https://doi.org/10.1007/978-3-658-07878-2der patient, these issues can be more difficult to tolerate and lead to various types of decompensation. In this chapter, we discuss their management and nutritional issues more specific to older patients.作者: Infect 時(shí)間: 2025-3-29 04:41 作者: Culpable 時(shí)間: 2025-3-29 11:00 作者: paleolithic 時(shí)間: 2025-3-29 12:43 作者: Foolproof 時(shí)間: 2025-3-29 16:28 作者: Prognosis 時(shí)間: 2025-3-29 23:05 作者: emission 時(shí)間: 2025-3-30 03:21
Living reference work 20200th editionompasses epidemiology, the biology and (patho)physiology of aging and cancer, geriatric assessment and management, hematologic malignancies, solid tumors, issues in patient care, and research methods. ?..Since cancer is a disease of aging and people are living longer, most cancer patients are now ag作者: 確保 時(shí)間: 2025-3-30 04:18
further information is acquired.Written by acknowledged expe.This book is intended as a comprehensive resource for clinicians and researchers seeking in-depth information on geriatric oncology. The coverage encompasses epidemiology, the biology and (patho)physiology of aging and cancer, geriatric as作者: 約會(huì) 時(shí)間: 2025-3-30 08:31 作者: 圓木可阻礙 時(shí)間: 2025-3-30 14:28
https://doi.org/10.1007/978-3-658-37209-5atively frequently transforms into the tumor (lymphoma) growth, it was interesting to analyze the existing data on overall role of the CCS in the processes of proliferation, apoptosis, aging, and malignant transformation of human lymphoid cells. This chapter summarizes these data.作者: 到婚嫁年齡 時(shí)間: 2025-3-30 16:42 作者: Customary 時(shí)間: 2025-3-30 23:13 作者: AGGER 時(shí)間: 2025-3-31 04:41
Calpain-Calpastatin System in Lymphoid Neoplasm of the Aged,atively frequently transforms into the tumor (lymphoma) growth, it was interesting to analyze the existing data on overall role of the CCS in the processes of proliferation, apoptosis, aging, and malignant transformation of human lymphoid cells. This chapter summarizes these data.作者: 大暴雨 時(shí)間: 2025-3-31 06:14 作者: chapel 時(shí)間: 2025-3-31 10:15
Comorbidity in Aging and Cancer,comorbidity is not always associated with worse outcomes from these therapies. Comprehensive geriatric assessment (CGA) along with assessment of patients’ goals and overall life expectancy can assist with decision-making in older adults with cancer and comorbidity.作者: 解脫 時(shí)間: 2025-3-31 14:34 作者: 預(yù)測(cè) 時(shí)間: 2025-3-31 18:08
,Zum gegenw?rtigen Stand der Forschung,hronic myeloproliferative diseases, with a strong correlation with toxicity and survival. Quality of life may also be improved with the new target therapy strategies approved not only in CML but also in primary myelofibrosis patients.作者: 賭博 時(shí)間: 2025-3-31 22:06 作者: PON 時(shí)間: 2025-4-1 05:40 作者: Throttle 時(shí)間: 2025-4-1 10:02
Daniel M?hle,Heinz-Roland M?hletive care. So geriatric status (frail or robust) influences the final treatment decision..If specific recommendations of management have been elaborated for older adults in colorectal cancers, efforts need to be made to produce management guidelines for other digestive cancers.作者: motor-unit 時(shí)間: 2025-4-1 11:19
Chronic Myelogenous Leukemia and Myeloproliferative Disorders in Older Adults,hronic myeloproliferative diseases, with a strong correlation with toxicity and survival. Quality of life may also be improved with the new target therapy strategies approved not only in CML but also in primary myelofibrosis patients.作者: 強(qiáng)制性 時(shí)間: 2025-4-1 14:43 作者: 身體萌芽 時(shí)間: 2025-4-1 18:42
Colorectal Cancer in Older Adults: Systemic Treatments,vacizumab in association with chemotherapy. There is a lack of evidence for the efficacy of anti-epidermal growth factor antibodies in elderly patients. Geriatric assessments could help to select the adequate treatment strategy for individual patients. Geriatric oncology is now the challenge we have to face, and more specific trials are needed.
